Vitamins for Eye Health: Lutein, Zeaxanthin and the Research

We spend over 10 hours a day looking at screens — should we be thinking about our eyes?

The average UK adult now spends more than 10 hours a day exposed to digital screens — phones, laptops, monitors, televisions. Interest in eye health supplements has surged accordingly, but which ingredients have genuine evidence behind them, and which are just marketing?

The answer is more nuanced than most supplement brands would like you to believe. Some nutrients carry EU-authorised health claims for vision. Others — most notably lutein — lack an authorised claim but have substantial clinical trial evidence. Understanding the difference matters.

Which nutrients have EU-authorised claims for vision?

Under EU Regulation 432/2012, retained in UK law post-Brexit, only a small number of nutrients are permitted to claim they contribute to the "maintenance of normal vision." These are the only authorised vision claims:

Vitamin A — contributes to the maintenance of normal vision
Zinc — contributes to the maintenance of normal vision
Riboflavin (vitamin B2) — contributes to the maintenance of normal vision
DHA (docosahexaenoic acid) — contributes to the maintenance of normal vision (at an intake of 250mg per day)

That is the complete list. No other nutrient — including lutein, zeaxanthin, vitamin C, or vitamin E — holds an authorised health claim specifically for vision under current UK and EU food law.

This does not mean other nutrients are irrelevant to eye health. It means the regulatory bar for an authorised claim is high, and the European Food Safety Authority (EFSA) has not yet approved claims for every nutrient with clinical evidence.

What are lutein and zeaxanthin?

Lutein and zeaxanthin are carotenoid pigments — the same class of compounds that give marigolds, sweetcorn, and peppers their yellow and orange colour. In the human body, these two carotenoids accumulate selectively in the macula, the small central region of the retina responsible for sharp, detailed vision.

Together, they form what is known as macular pigment — a yellow-pigmented layer that sits in front of the photoreceptor cells. Macular pigment performs two key functions:

Filtering high-energy blue light before it reaches the photoreceptors, reducing potential photo-oxidative damage
Acting as antioxidants within the retinal tissue, neutralising reactive oxygen species generated by light exposure

The concentration of lutein and zeaxanthin in the macula is measured as macular pigment optical density (MPOD). Higher MPOD is consistently associated with better visual performance, including improved contrast sensitivity and reduced glare disability.

Despite this body of evidence, lutein and zeaxanthin do not currently hold EU-authorised health claims for vision. The distinction is important: the evidence exists, but EFSA has not approved a specific claim wording.

What did the AREDS2 study find?

The Age-Related Eye Disease Study 2 (AREDS2) is the landmark clinical trial for eye health supplementation. Published in JAMA in 2013, this large, multicentre, randomised controlled trial enrolled 4,203 participants aged 50–85 who were at risk of progression to advanced age-related macular degeneration (AMD).

The key finding: lutein (10mg) and zeaxanthin (2mg) were a safe and effective replacement for beta-carotene in the original AREDS formula. Participants who received lutein and zeaxanthin in place of beta-carotene showed a further reduction in risk of progression to advanced AMD compared with those receiving beta-carotene.

This was significant because beta-carotene had been linked to increased lung cancer risk in smokers, making the lutein/zeaxanthin substitution both safer and at least as effective.

The full AREDS2 formula tested included vitamin C (500mg), vitamin E (400 IU), zinc (80mg), copper (2mg), lutein (10mg), and zeaxanthin (2mg).

Does lutein help with blue light from screens?

This is the question most people under 50 are really asking — and the evidence is promising, though the research has largely focused on macular pigment density rather than screen-specific outcomes.

Macular pigment absorbs blue light (wavelengths around 400–500nm) before it reaches the photoreceptors. Higher MPOD means more blue light is filtered. Several studies have demonstrated that lutein and zeaxanthin supplementation increases MPOD:

Stringham & Hammond (2008) showed that six months of lutein and zeaxanthin supplementation significantly increased macular pigment optical density and improved visual performance under glare conditions — including reduced glare disability and faster photostress recovery.

Kvansakul et al. (2006) found that supplementation with lutein or zeaxanthin produced statistically significant improvements in contrast acuity thresholds and increased macular pigment optical density, with particular benefits at low illumination levels.

The logic connecting these findings to screen use is straightforward: digital screens emit significant amounts of blue light, lutein and zeaxanthin filter blue light in the macula, and supplementation increases the density of this filtering pigment. However, it is worth noting that no large-scale trial has yet specifically measured the effect of lutein supplementation on outcomes in heavy screen users. The evidence supports the mechanism, not yet a specific screen-related endpoint.

How does zinc contribute to normal vision?

Zinc carries the EU-authorised claim that it "contributes to the maintenance of normal vision" — and with good reason. Zinc is found in high concentrations in the retina and the retinal pigment epithelium (RPE), the tissue layer that supports and nourishes the photoreceptor cells.

Zinc plays several roles in the eye:

It is essential for the activity of retinol dehydrogenase, the enzyme that converts retinol (vitamin A) to retinaldehyde — a necessary step in the visual cycle
It contributes to normal protein synthesis and cell division in the rapidly renewing retinal tissue
It was included in both the original AREDS formula and the AREDS2 formula at a dose of 80mg (with 2mg copper to prevent zinc-induced copper deficiency)

PARTICULAR includes zinc in its formulation and adjusts the dose based on your questionnaire responses, accounting for dietary intake and other factors that affect zinc requirements.

What role does vitamin A play in vision?

Vitamin A has the most fundamental relationship with vision of any nutrient. It contributes to the maintenance of normal vision through its role in producing rhodopsin — the light-sensitive pigment in the rod cells of the retina that enables vision in low-light conditions.

Without adequate vitamin A, the rod cells cannot regenerate rhodopsin after it is bleached by light exposure. This is why severe vitamin A deficiency causes night blindness (nyctalopia) — one of the earliest recognised nutritional deficiency diseases.

PARTICULAR uses retinyl acetate, a preformed vitamin A ester that does not require conversion from plant-based precursors and is suitable for a vegan formulation. The dose is calibrated through the questionnaire to complement dietary intake without risk of excessive consumption.

How do vitamin C and vitamin E support the eyes?

Vitamin C and vitamin E do not carry authorised vision-specific health claims, but both were included in the AREDS2 formula based on their roles as antioxidants in ocular tissue.

Vitamin C is present in the aqueous humour (the fluid in the front of the eye) at concentrations significantly higher than in blood plasma. It contributes to the protection of cells from oxidative stress — an authorised claim — and the retina is among the most oxidatively stressed tissues in the body due to its high metabolic rate and constant light exposure.

Vitamin E contributes to the protection of cells from oxidative stress and is the primary lipid-soluble antioxidant in cell membranes, including the lipid-rich photoreceptor membranes. It was included in AREDS2 at 400 IU (as dl-alpha-tocopherol).

Both nutrients work alongside lutein and zeaxanthin as part of the retina's antioxidant defence system. The AREDS2 trial tested them as a combined formula, not in isolation, so their individual contributions to the overall result cannot be separated from the data.

How does PARTICULAR deliver eye health nutrients?

PARTICULAR includes lutein, zinc, vitamin A, vitamin C, and vitamin E in its personalised microgranule formula. The delivery format matters for these nutrients in particular:

Lutein is a carotenoid and therefore sensitive to oxidation, heat, and light. In PARTICULAR's microgranule format, each granule containing lutein is individually enteric-coated, protecting the carotenoid from degradation in the stomach and ensuring release in the intestine where fat-soluble nutrients are best absorbed
Lutein is sourced from Tagetes erecta (marigold) oleoresin — a standardised, vegan source used in the majority of clinical trials, including AREDS2
Zinc and vitamin C are released independently from each other and from calcium, avoiding competitive inhibition at absorption sites in the intestine
Doses are personalised — the questionnaire captures your screen time, dietary patterns, and eye health goals, and adjusts the formula accordingly. Someone who spends 12 hours a day at a screen and eats few carotenoid-rich foods will receive a different formula from someone who works outdoors and eats leafy greens daily

Your daily scoop of loose microgranules contains each nutrient in its own independently coated granule — not compressed together in a single tablet where interactions and degradation are unavoidable. Read more about how this works on our science page.

Key takeaways

Only four nutrients hold EU-authorised claims for "maintenance of normal vision": vitamin A, zinc, riboflavin, and DHA
Lutein and zeaxanthin do not have authorised vision claims, but the AREDS2 trial and multiple studies demonstrate their role in macular pigment and blue light filtration
The AREDS2 study — the largest eye health supplement trial — found lutein and zeaxanthin were a safe and effective replacement for beta-carotene
Supplementation with lutein and zeaxanthin has been shown to increase macular pigment optical density and improve visual performance under glare
Zinc and vitamin A play essential roles in the visual cycle and retinal tissue maintenance
Vitamin C and vitamin E contribute to antioxidant protection in ocular tissue and were part of the AREDS2 formula
PARTICULAR delivers these nutrients in individually enteric-coated microgranules, protecting sensitive carotenoids from oxidation and ensuring intestinal absorption
Your formula is personalised through the questionnaire based on screen time, diet, and eye health goals

Sources cited in this article: